|
Malignant neoplasm of prostate
|
0.360 |
Biomarker
|
disease |
BEFREE |
LncRNA NEAT1 promotes docetaxel resistance in prostate cancer by regulating ACSL4 via sponging miR-34a-5p and miR-204-5p.
|
31672604 |
2020 |
|
Malignant neoplasm of prostate
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
The results showed that NEAT1 was significantly up-regulated in PCa tissues and PCa cell lines.
|
31481527 |
2019 |
|
Malignant neoplasm of prostate
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
By taking advantage of the prostate cancer tumor transcriptome profiles from The Cancer Genome Atlas, our data-mining pipeline identified a series of transcription factors (TF) whose regulatory activities on target genes depended on the level of NEAT1.
|
29871935 |
2018 |
|
Malignant neoplasm of prostate
|
0.360 |
Biomarker
|
disease |
BEFREE |
The progressive emergence of the ERα and ERα-regulated genes (eg, progesterone receptor (PR), PS2, TMPRSS2-ERG fusion, and NEAT1) during prostate cancer progression and hormone refractory disease suggests that these tumors can bypass the AR by using estrogens and progestins for their growth.
|
29094395 |
2018 |
|
Malignant neoplasm of prostate
|
0.360 |
Biomarker
|
disease |
CTD_human |
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
|
29662167 |
2018 |
|
Malignant neoplasm of prostate
|
0.360 |
Biomarker
|
disease |
BEFREE |
In function, NEAT1 promoted the prostate cancer cell growth through IGF1R/AKT signaling pathway.
|
29225160 |
2018 |
|
Malignant neoplasm of prostate
|
0.360 |
AlteredExpression
|
disease |
BEFREE |
Prostate cancer cells expressing high levels of NEAT1 were recalcitrant to androgen or AR antagonists.
|
25415230 |
2014 |
|
Liver neoplasms
|
0.320 |
Biomarker
|
group |
BEFREE |
The effect of NEAT1 on tumor growth was observed in a mice model of transplanted hepatoma.
|
31819522 |
2019 |
|
Malignant neoplasm of liver
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
The expression of transcript variants of NEAT1 and transcripts encoding the paraspeckle-associated proteins was analysed in the TCGA liver cancer data set.
|
30946555 |
2019 |
|
Malignant neoplasm of liver
|
0.320 |
AlteredExpression
|
disease |
BEFREE |
Our data showed that increase NEAT1_2 and SFPQ expressions in liver cancer specimens were associated with the development of cisplatin resistance; high SFPQ expression level impaired patients' survival from liver cancer.
|
30254462 |
2018 |
|
Liver neoplasms
|
0.320 |
Biomarker
|
group |
BEFREE |
The effect of NEAT1 on tumor growth was observed in mouse models of transplanted hepatoma.
|
28526689 |
2017 |
|
Liver neoplasms
|
0.320 |
Biomarker
|
group |
CTD_human |
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
|
27064257 |
2016 |
|
Malignant neoplasm of liver
|
0.320 |
Biomarker
|
disease |
CTD_human |
Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer.
|
27064257 |
2016 |
|
Prostatic Neoplasms
|
0.300 |
Biomarker
|
group |
CTD_human |
Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets.
|
29662167 |
2018 |
|
Juvenile-Onset Still Disease
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Juvenile arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Juvenile psoriatic arthritis
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Polyarthritis, Juvenile, Rheumatoid Factor Negative
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Polyarthritis, Juvenile, Rheumatoid Factor Positive
|
0.300 |
Biomarker
|
disease |
CTD_human |
Gene expression signatures in polyarticular juvenile idiopathic arthritis demonstrate disease heterogeneity and offer a molecular classification of disease subsets.
|
19565504 |
2009 |
|
Leukemia, Myelocytic, Acute
|
0.110 |
Biomarker
|
disease |
BEFREE |
Long noncoding RNA NEAT1 modulates cell proliferation and apoptosis by regulating miR-23a-3p/SMC1A in acute myeloid leukemia.
|
30246348 |
2019 |
|
Leukemia, Myelocytic, Acute
|
0.110 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
|
Malignant neoplasm of breast
|
0.100 |
Biomarker
|
disease |
BEFREE |
Identification of lncRNA NEAT1/miR-21/RRM2 axis as a novel biomarker in breast cancer.
|
31621912 |
2020 |
|
Malignant Neoplasms
|
0.100 |
AlteredExpression
|
group |
BEFREE |
Corrigendum to "Prognostic Effect of Long Noncoding RNA NEAT1 Expression Depends on p53 Mutation Status in Cancer".
|
31485225 |
2020 |
|
Colorectal Carcinoma
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
We found that NEAT1 expression was increased in CRC tissues and cells, which showed a negative correlation with miR-34a expression.
|
31802650 |
2020 |
|
Malignant neoplasm of stomach
|
0.100 |
Biomarker
|
disease |
BEFREE |
Kaplan-Meier's analysis was performed to evaluate the relationship between NEAT1 and poor prognosis in GC.
|
31617275 |
2020 |